SCHEMBL200241

SCHEMBL200241

O=C(O)[C@H]1CCCN1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3262654 1.00 ACE (0.44)
SCHEMBL7411 1.00
SCHEMBL8089 1.00
Methane SCHEMBL14937660 0.98 ACE (0.43)
Hydrochloric Acid SCHEMBL11775905 0.98 ACE (0.43)
SCHEMBL29507635 0.98 ACE (0.43)
Water SCHEMBL28773339 0.98 ACE (0.43)
SCHEMBL9312770 0.98 ACE (0.43)
Ammonia Solution, Strong SCHEMBL20920825 0.98 ACE (0.43)
Ammonia Solution, Strong SCHEMBL28912295 0.98 ACE (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 595 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260098072-A1 METHODS OF STIMULATING APPETITE AND/OR INCREASING BODY WEIGHT USING NON-NATURALLY OCCURRING MELANOCORTIN RECEPTOR ANTAGONIST ANALOGS ENDEVICA BIO INC (US) 2026-04-09 US claimed
EP-4665374-A1 METHODS OF PREVENTING AND/OR TREATING SIDE EFFECTS ASSOCIATED WITH ANTI-CANCER AGENTS USING NON-NATURALLY OCCURRING MELANOCORTIN ANALOGS WITH ANTI-GDF-15 ANTIBODIES Endevica Bio, Inc. (US) 2025-12-24 EP claimed
WO-2025245279-A1 NON-NATURALLY OCCURRING MELANOCORTIN RECEPTOR AGONISTS AND USE THEREFORE IN TREATMENT OF ADDICTION AND/OR PAIN ENDEVICA BIO, INC. (US) 2025-11-27 WO claimed
EP-4629981-A2 SMALL MOLECULE DEGRADERS OF C-SRC KINASE The Regents Of The University Of Michigan (US) 2025-10-15 EP claimed
EP-4605407-A2 METHODS OF STIMULATING APPETITE AND/OR INCREASING BODY WEIGHT USING NON-NATURALLY OCCURRING MELANOCORTIN RECEPTOR ANTAGONIST ANALOGS Endevica Bio, Inc. (US) 2025-08-27 EP claimed
EP-4590347-A1 NOVEL MINIGASTRIN-DERIVED CHOLECYSTOKININ 2 RECEPTOR BINDING MOLECULES FOR IMAGING AND TARGETED RADIOTHERAPY Technische Universität München (DE) 2025-07-30 EP claimed
WO-2025123059-A1 NON-NATURALLY OCCURRING MELANOCORTIN ANALOGS AND USES THEREOF FOR TREATING SUBSTANCE USE DISORDERS ENDEVICA BIO, INC. (US) 2025-06-12 WO claimed
CN-119907695-A Novel small gastrin-derived cholecystokinin 2 receptor binding molecules for imaging and targeted radiotherapy 慕尼黑工业大学 2025-04-29 CN claimed
WO-2024177909-A1 METHODS OF STIMULATING APPETITE AND/OR INCREASING BODY WEIGHT IN SUBJECTS HAVING A FIBROTIC DISEASE USING NON-NATURALLY OCCURRING MELANOCORTIN ANALOGS ENDEVICA BIO, INC. (US) 2024-08-29 WO claimed
WO-2024177907-A2 METHODS OF TREATING CANCER AND/OR CHEMOTHERAPY RELATED CONDITIONS USING NON-NATURALLY OCCURRING MELANOCORTIN ANALOGS ENDEVICA BIO, INC. (US) 2024-08-29 WO claimed
US-5352769-A Genetic engineering ELI LILLY AND COMPANY (US) 1994-10-04 US claimed
EP-0383472-A2 Insulin analogs ELI LILLY AND COMPANY (US) 1990-08-22 EP claimed
EP-0176070-B1 PHARMACOLOGICALLY ACTIVE PEPTIDES Brantl, Victor, Dr. med., Dipl.-Chem. (DE) 1989-04-19 EP claimed
US-4657892-A ANALGESICS, HYPOTENSIVE AGENTS BRANTL VICTOR (DE) 1987-04-14 US claimed
EP-0137339-B1 PHARMACOLOGICALLY ACTIVE PEPTIDES Brantl, Victor, Dr. med., Dipl.-Chem. (DE) 1987-03-18 EP claimed
EP-0197059-A1 PHARMACOLOGICALLY ACTIVE PEPTIDE Brantl, Victor, Dr. med., Dipl.-Chem. (DE) 1986-10-15 EP claimed
WO-1986002079-A1 PHARMACOLOGICALLY ACTIVE PEPTIDE BRANTL VICTOR (DE) 1986-04-10 WO claimed
EP-0176070-A1 Pharmacologically active peptides Brantl, Victor, Dr. med., Dipl.-Chem. (DE) 1986-04-02 EP claimed
EP-0137339-A1 Pharmacologically active peptides Brantl, Victor, Dr. med., Dipl.-Chem. (DE) 1985-04-17 EP claimed
WO-1985001292-A1 PHARMACOLOGICALLY ACTIVE PEPTIDES BRANTL VICTOR 1985-03-28 WO claimed